Glenn W. Welling
Engaged Capital
Engaged Capital Portfolio 13F
Glenn W. Welling Holdings Activity
- Portfolio value:
- $539.33M≈ (-$174M≈)
- Previous value:
- $712.90M≈
- # of changes:
- 14
- New positions:
- 2
- Reported for:
- 31 Dec 2018 (Q4)
- Latest filing date:
- 14 Feb 2019
Engaged Capital has disclosed a total of 14 changes to the portfolio in the (2018 Q4) SEC report(s): increased the number of shares of 3, bought 2 totally new, decreased the number of shares of 6 and completely sold out 3 position(s).
What stocks did Glenn W. Welling buy in 2018 Q4?
During 2018 Q4 Glenn W. Welling has purchased 5 securities: (UPBD) Upbound Group Inc (added shares +17.65%), (APOG) Apogee Enterprises Inc (added shares +13.30%), (DFRG) Del Frisco's Restaurant Group Inc (new buy), (MGLN) Magellan Health Inc (new buy) and (INWK) InnerWorkings Inc (added shares +51.49%).
What did Glenn W. Welling invest in during 2018 Q4?
Warning: SEC insider reports detected for Engaged Capital (real-time trades and ownership disclosures)
1 transaction as of 2 months ago and 2 ownership disclosures as of 2 months ago
14 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Del Frisco's Restaurant Group Inc
|
new
|
$7.15
|
|
4.41%
|
2018 Q4
|
≈ 0.25 years
|
||||
|
|
Magellan Health Inc
|
new
|
$56.89
|
|
2.70%
|
2018 Q4
|
≈ 0.25 years
|
||||
|
|
InnerWorkings Inc
|
+51.49%
|
$3.74
|
|
1.79%
|
2018 Q3
|
≈ 0.50 years
|
||||
|
|
Upbound Group Inc
|
+17.65%
|
$16.19
|
+28.29%($20.77)
|
16.01%
|
2016 Q4
|
≈ 2.25 years
|
||||
|
|
Apogee Enterprises Inc
|
+13.30%
|
$29.85
|
+43.05%($42.70)
|
9.35%
|
2017 Q4
|
≈ 1.25 years
|
||||
|
|
NCR Voyix Corp
|
-0.24%
|
$23.08
|
-62.24%($8.72)
|
4.61%
|
2017 Q3
|
≈ 1.50 years
|
||||
|
|
Benchmark Electronics Inc
|
-1.41%
|
$21.18
|
+306.52%($86.10)
|
8.78%
|
2015 Q1
|
≈ 4.00 years
|
||||
|
|
Groupon Inc
|
-2.80%
|
$64.00
|
-55.72%($28.34)
|
1.45%
|
2018 Q2
|
≈ 0.75 years
|
||||
|
|
Anika Therapeutics Inc
|
-3.10%
|
$33.61
|
-42.55%($19.31)
|
2.34%
|
2018 Q2
|
≈ 0.75 years
|
||||
|
|
Aratana Therapeutics Inc
|
-14.22%
|
$6.13
|
|
3.96%
|
2018 Q1
|
≈ 1.00 year
|
||||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.